NO973034L - Apoptose-modulerende preparat omfattende en faktor som påvirker det intracellulære nivå av methional eller malondialdehyd - Google Patents

Apoptose-modulerende preparat omfattende en faktor som påvirker det intracellulære nivå av methional eller malondialdehyd

Info

Publication number
NO973034L
NO973034L NO973034A NO973034A NO973034L NO 973034 L NO973034 L NO 973034L NO 973034 A NO973034 A NO 973034A NO 973034 A NO973034 A NO 973034A NO 973034 L NO973034 L NO 973034L
Authority
NO
Norway
Prior art keywords
methional
malondialdehyde
factor affecting
intracellular level
apoptosis
Prior art date
Application number
NO973034A
Other languages
English (en)
Norwegian (no)
Other versions
NO973034D0 (no
Inventor
Georges Anthony Quash
Alain Doutheau
Original Assignee
Cird Galderma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cird Galderma filed Critical Cird Galderma
Publication of NO973034D0 publication Critical patent/NO973034D0/no
Publication of NO973034L publication Critical patent/NO973034L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/11—Aldehydes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO973034A 1994-12-29 1997-06-27 Apoptose-modulerende preparat omfattende en faktor som påvirker det intracellulære nivå av methional eller malondialdehyd NO973034L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9415884A FR2728790B1 (fr) 1994-12-29 1994-12-29 Composition modulant l'apoptose comprenant du methonial ou tout facteur influencant le taux intracellulaire de methonial
PCT/FR1995/001715 WO1996020701A1 (fr) 1994-12-29 1995-12-22 Composition modulant l'apoptose comprenant un facteur influençant le taux intracellulaire de methional ou de malondialdehyde

Publications (2)

Publication Number Publication Date
NO973034D0 NO973034D0 (no) 1997-06-27
NO973034L true NO973034L (no) 1997-08-29

Family

ID=9470424

Family Applications (1)

Application Number Title Priority Date Filing Date
NO973034A NO973034L (no) 1994-12-29 1997-06-27 Apoptose-modulerende preparat omfattende en faktor som påvirker det intracellulære nivå av methional eller malondialdehyd

Country Status (24)

Country Link
US (1) US5744499A (ja)
EP (1) EP0723778B1 (ja)
JP (1) JP2000515845A (ja)
KR (1) KR100310499B1 (ja)
AR (1) AR001783A1 (ja)
AT (1) ATE191339T1 (ja)
AU (1) AU704064B2 (ja)
BR (1) BR9510509A (ja)
CA (1) CA2166243C (ja)
DE (1) DE69516107T2 (ja)
DK (1) DK0723778T3 (ja)
ES (1) ES2147272T3 (ja)
FI (1) FI972780A (ja)
FR (1) FR2728790B1 (ja)
GR (1) GR3033732T3 (ja)
HU (1) HUT77490A (ja)
IL (1) IL116586A0 (ja)
NO (1) NO973034L (ja)
NZ (1) NZ298831A (ja)
PL (1) PL182597B1 (ja)
PT (1) PT723778E (ja)
RU (1) RU2160103C2 (ja)
WO (1) WO1996020701A1 (ja)
ZA (1) ZA9511015B (ja)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9517622D0 (en) * 1995-08-29 1995-11-01 Univ Edinburgh Regulation of intracellular glucocorticoid concentrations
FR2761606B1 (fr) * 1997-04-08 1999-05-14 Cird Galderma Utilisation de derives aminothiolesters dans le domaine pharmaceutique
US8541469B2 (en) * 1997-08-23 2013-09-24 Glaxo Group Limited Treatment of cell-mediated immune diseases
EP0908179A1 (en) * 1997-08-23 1999-04-14 Werner Bollag Treatment of cell-mediated immune diseases
US7951989B2 (en) * 1998-02-23 2011-05-31 Phylonix Pharmaceuticals, Inc. Methods of screening agents for activity using teleosts
US6656449B1 (en) * 1998-02-23 2003-12-02 Phylonix Pharmaceuticals, Inc. Methods of screening agents for activity using teleosts
AU749688B2 (en) * 1998-02-23 2002-07-04 Phylonix Pharmaceuticals, Inc. Methods of screening agents for activity using teleosts
BR9908713A (pt) * 1998-03-16 2000-11-21 Somerset Pharmaceuticals Inc Uso de selegilina ou desmetil-selegilina para tratamento de feridas, queimaduras e danos dermatológicos
FR2777001B1 (fr) * 1998-04-01 2000-06-09 Cird Galderma Derives de l'acide 6,8-dimercaptooctanoique substitues en 6-s et/ou en 8-s par le radical (3-methylthiopropanoyl) et compositions pharmaceutiques destinees au traitement des tumeurs cancereuses
TW544310B (en) 1998-04-02 2003-08-01 Ajinomoto Kk Amino acid derivatives and anti-inflammatory agents
EP1135531B1 (en) 1998-12-01 2007-05-02 Phylonix Pharmaceuticals Inc. Methods for introducing heterologous cells into fish
AU1784301A (en) * 1999-11-24 2001-06-04 Alticor Inc. Topical skin composition
ES2531547T3 (es) * 1999-12-06 2015-03-17 Geistlich Pharma Ag Uso de taurolidina o el taurultamo para la fabricación de un medicamento para el tratamiento de tumores
US20080124409A1 (en) * 2000-11-21 2008-05-29 Access Business Group International Llc Topical Skin Compositions, Their Preparation, and Their Use
US20070003536A1 (en) * 2000-11-21 2007-01-04 Zimmerman Amy C Topical skin compositions, their preparation, and their use
JP2004532245A (ja) * 2001-05-15 2004-10-21 ページ ダブル フォーク 癌を治療するための生体影響性化合物の標的送達
US20030129262A1 (en) * 2001-08-30 2003-07-10 Epner Daniel E. Methionine restriction for cancer therapy
US20030143645A1 (en) * 2001-09-14 2003-07-31 Haystead Timothy A. Quinone reductase 2 and aldehyde dehydrogenase as therapeutic targets
JP2004020220A (ja) * 2002-06-12 2004-01-22 Pioneer Electronic Corp 通信システム及び方法、通信端末装置、通信センタ装置、並びにコンピュータプログラム
US20050152995A1 (en) * 2003-06-27 2005-07-14 Chen Dong F. Methods and compositions for promoting axon regeneration and cell replacement therapy
WO2009144253A1 (en) * 2008-05-29 2009-12-03 Karolinska Institutet Innovations Ab Compounds comprising a 3-pyridinol or 5-pyrimidinol ring having an organoseleno or organotelluro substituent for use as antioxidants
SE537517C2 (sv) 2012-12-14 2015-05-26 Stora Enso Oyj Våtlagt arkmaterial innefattande mikrofibrillerad cellulosasamt förfarande för tillverkning därav
WO2017005910A1 (en) * 2015-07-09 2017-01-12 Metabolic Explorer Methionine hydroxy analog (mha) pathways for production by fermentation

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5716898A (en) * 1980-07-03 1982-01-28 Kureha Chem Ind Co Ltd Prostaglandin controller containing aminobenzoic derivative
HU201240B (en) * 1987-03-18 1990-10-28 Caola Kozmetikai Cosmetical composition for regeneration of skin
FR2673530B1 (fr) * 1991-03-06 1995-05-19 Monique Moreau Extraits de feuilles de murier, antiradicalaires et antimalondialdehyde.

Also Published As

Publication number Publication date
FI972780A0 (fi) 1997-06-27
ATE191339T1 (de) 2000-04-15
IL116586A0 (en) 1996-03-31
ZA9511015B (en) 1996-08-12
KR970706807A (ko) 1997-12-01
DK0723778T3 (da) 2000-07-10
PL182597B1 (pl) 2002-02-28
GR3033732T3 (en) 2000-10-31
EP0723778B1 (fr) 2000-04-05
PL320963A1 (en) 1997-11-24
CA2166243C (fr) 2003-07-01
ES2147272T3 (es) 2000-09-01
US5744499A (en) 1998-04-28
RU2160103C2 (ru) 2000-12-10
FR2728790B1 (fr) 1997-01-24
HUT77490A (hu) 1998-05-28
AU4451296A (en) 1996-07-24
EP0723778A1 (fr) 1996-07-31
MX9704491A (es) 1997-10-31
KR100310499B1 (ko) 2001-12-12
AU704064B2 (en) 1999-04-15
FR2728790A1 (fr) 1996-07-05
WO1996020701A1 (fr) 1996-07-11
DE69516107T2 (de) 2000-11-16
JP2000515845A (ja) 2000-11-28
NZ298831A (en) 2001-04-27
PT723778E (pt) 2000-09-29
DE69516107D1 (de) 2000-05-11
AR001783A1 (es) 1997-12-10
CA2166243A1 (fr) 1996-06-30
FI972780A (fi) 1997-06-27
NO973034D0 (no) 1997-06-27
BR9510509A (pt) 1998-07-07

Similar Documents

Publication Publication Date Title
NO973034L (no) Apoptose-modulerende preparat omfattende en faktor som påvirker det intracellulære nivå av methional eller malondialdehyd
ES2060910T3 (es) Peptidos que tienen actividad antagonista de taquiquinina, un procedimiento para su preparacion y composiciones farmaceuticas que los comprenden.
ES2061252T3 (es) Agente antitusivo y regulador de la mucosa, procedimiento para su preparacion y composiciones farmaceuticas que lo contienen.
NO950774L (no) Fremgangsmåte for inhibering av bentap og nedsettelse av serumkolesterol
SE8503680D0 (sv) Indolderivat
ES2088312T3 (es) Formulacion de liberacion controlada que contiene tramadol.
WO2005011627A3 (en) Regulation of mammalian keratinous tissue using n-acyl amino acid compositons
DK0562956T3 (da) Hidtil ukendte naphthylalkylaminer, fremgangsmåde til fremstilling heraf og farmaceutiske midler, som indeholder dem
DE3785136D1 (de) Arzneimittel zur inhibition von hautfalte.
ATE424810T1 (de) Ein hydrokolloid und einen celluloseether enthaltende tablette mit verzögerter freisetzung
SK282579B6 (sk) Parenterálne farmaceutické prípravky a spôsob ich prípravy
AU5910996A (en) Pyrrole derivatives and medicinal composition
NO941977L (no) Indolderivater, fremgangsmåte for fremstilling av disse, og medisinsk anvendelse derav
KR20010049430A (ko) 산소-불안정성 종을 안정화시키기 위한 조성물
ECSP930933A (es) Composicion farmaceutica y procedimiento para prepararla
AU7351881A (en) Stabilization of pharmaceutical compositions containing acid addition salts of thieno-pyridine derivatives
HUT70531A (en) Arylmorpholine derivatives, pharmaceutical compositions containing them as active agent and process for preparing them
DK122191A (da) Benzimidazolderivat og fysiologisk acceptable salte heraf samt fremgangsmaade til fremstilling af samme
NO20045132L (no) Benzo(c)kinolizinderivater, deres fremstilling og anvendelse som 5alfa- reduktaseinhibitorer
DK0486385T3 (da) Imidazolderivater, fremgangsmåde til fremstilling heraf og farmaceutiske midler, som indeholder dem
TW280810B (ja)
DE69318715D1 (de) Pharmakologisch aktive alpha-(tertiär-aminoethyl)-phenylmethanol-derivate
DK0632717T3 (da) Middel til anvendelse som et anti-irritationsmiddel
ES2065855B1 (es) Procedimiento para la preparacion de nuevos derivados desoxiazafosfolipidicos con accion inhibidora de la fosfolipasa a2, nuevos derivados desoxiazafosfolipidicos obtenidos y utilizacion de los mismos.
ES2055121T3 (es) Procedimiento de preparacion de nuevos derivados trienicos de estructura cromenica, y los compuestos farmaceuticos que contienen estos derivados.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application